Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models
- PMID: 21262379
- DOI: 10.1016/j.drudis.2011.01.003
Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models
Abstract
The future of nucleic acid-based therapeutics is dependent on achieving successful delivery. Recently, there has been an increasing interest in delivery via the gastrointestinal tract. Gene therapy via this route has many advantages, including non-invasive access and the versatility to treat local diseases, such as inflammatory bowel disease, as well as systemic diseases, such as haemophilia. However, the intestine presents several distinct barriers and, therefore, the design of robust non-viral delivery systems is key to future success. Several non-viral delivery strategies have provided evidence of activity in vivo. To facilitate the design of more efficient and safe gene medicines, more physiologically relevant models, at both the in vitro and in vivo levels, are essential.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies.Int J Pharm. 2012 May 1;427(1):3-20. doi: 10.1016/j.ijpharm.2011.07.013. Epub 2011 Jul 22. Int J Pharm. 2012. PMID: 21798324 Review.
-
Vectors for pulmonary gene therapy.Int J Pharm. 2010 May 5;390(1):84-8. doi: 10.1016/j.ijpharm.2009.10.010. Epub 2009 Oct 13. Int J Pharm. 2010. PMID: 19825403 Review.
-
What role can chemistry play in cationic liposome-based gene therapy research today?Adv Genet. 2005;53:71-118. Adv Genet. 2005. PMID: 16240991 Review.
-
Current status of polymeric gene delivery systems.Adv Drug Deliv Rev. 2006 Jul 7;58(4):467-86. doi: 10.1016/j.addr.2006.03.007. Epub 2006 Jun 15. Adv Drug Deliv Rev. 2006. PMID: 16781003 Review.
-
Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?Biotechnol Adv. 2011 Jul-Aug;29(4):402-17. doi: 10.1016/j.biotechadv.2011.03.003. Epub 2011 Mar 22. Biotechnol Adv. 2011. PMID: 21435387 Review.
Cited by
-
Gene and cell therapy based treatment strategies for inflammatory bowel diseases.World J Gastrointest Pathophysiol. 2011 Dec 15;2(6):114-22. doi: 10.4291/wjgp.v2.i6.114. World J Gastrointest Pathophysiol. 2011. PMID: 22180846 Free PMC article.
-
In vitro and in vivo models for the study of oral delivery of nanoparticles.Adv Drug Deliv Rev. 2013 Jun 15;65(6):800-10. doi: 10.1016/j.addr.2013.01.003. Epub 2013 Feb 13. Adv Drug Deliv Rev. 2013. PMID: 23415952 Free PMC article. Review.
-
Peptides as drug delivery vehicles across biological barriers.J Pharm Investig. 2018 Jan;48(1):89-111. doi: 10.1007/s40005-017-0374-0. Epub 2017 Dec 12. J Pharm Investig. 2018. PMID: 29963321 Free PMC article.
-
Therapeutic applications of hydrogels in oral drug delivery.Expert Opin Drug Deliv. 2014 Jun;11(6):901-15. doi: 10.1517/17425247.2014.902047. Expert Opin Drug Deliv. 2014. PMID: 24848309 Free PMC article. Review.
-
Evaluating the effect of food components on the digestion of dietary nucleic acids in human gastric juice in vitro.Food Sci Nutr. 2023 Aug 6;11(10):6522-6531. doi: 10.1002/fsn3.3599. eCollection 2023 Oct. Food Sci Nutr. 2023. PMID: 37823154 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
